Press Releases  (View all Press Releases)

Waltham, MA - July 22, 2010
PAREXEL Chairman and CEO Named Executive of the Year in North America in International Business Awards
Josef von Rickenbach, a member of the Boston Millennia Advisory Board and Chairman and CEO of PAREXEL, was named Executive of the Year in North America in the seventh annual International Business Awards SM, which celebrate excellence worldwide.

Waltham, MA - July 8, 2010
Histogenics Begins Phase III Study of NeoCart® Implant for Knee Repair
Boston Millennia Partners portfolio company, Histogenics, announced today that it has launched the Phase III study of cartilage repair to evaluate the NeoCart® autologous tissue implant in repairing knee cartilage injury. The study is the largest in the U.S. comprised of 245 patients.

Boston, MA - July 1, 2010
MedAptus Awarded United States Patent for Technology to Process and Reconcile Professional and Technical Charges
Boston Millennia Partners portfolio company, MedAptus, has been awarded a U.S. patent entitled "Method and System for Processing Medical Billing Records." The patent pertains to MedAptus' automated process for capturing both professional and facility charges in outpatient settings.

Cambridge, MA - June 23, 2010
Patrick Fortune, Ph.D. to Moderate Healthcare Roundtable at Venture Summit East at Harvard Business School
Dr. Patrick Fortune will moderate a healthcare round table discussion as part of Venture Summit East; a two-day gathering that highlights the significant economic, political and technology trends impacting the global growth investor.

Boston, MA - June 17, 2010
Dana Callow to participate in XSITE 2010: The Xconomy Summit on Innovation, Technology & Entrepreneurship
Dana Callow will present as part of a panel on the state of venture capital investing as part of the XSITE 2010 Summit being held at Babson College.

Boston, MA - April 28, 2010
Dr. Patrick Fortune to participate in the MassBio panel "State of Play – The Changing Life Cycle of the Life Science Company"
Patrick Fortune participating in panel for the MassBio conference discussing issues facing VC’s with LP re-allocations and returns expectation, new strategies for de-risking and funding life science development stories and discovery vs. development strategies. http://www.massbio.org/events